Liraglutide Expected to Improve Glycemic Control and Preserve Beta-Cells in Uncontrolled Type 1 Diabetes
GLP-1 Analogue Treatment in Uncontrolled Type 1 Diabetic Patients
Abstract
Liraglutide is hypothesized to improve glycemic control in uncontrolled type 1 diabetic patients, with an expected 1% reduction in HbA1c from baseline.
TitrateLab articles covering Liraglutide
Written by TitrateLab, separately from the study summarized above.
